Rydapt set for EU approval after Novartis addresses CHMP concerns

 
• By Maureen Kenny
Targets hit in the center by arrows
Rydapt would be first targeted treatment in the EU for certain AML patients • Source: Shutterstock

More from Europe

More from Geography